Biotech Values

[exwannabe]

MNTA At 10% it moves the quarterly loss up to the 20-25 cent range.

Long term. But for now we have:

. 5 weeks full profit split in Q1

. Refund (partial?) of the R&D payback that was given to NVS upon sole approval (did not MNTA say that over a year ago?).

These will keep the loss and burn down for a while.